Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33140760" target="_blank" >RIV/61989592:15110/12:33140760 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00843989:_____/12:00102948 RIV/00843989:_____/12:00102949

Výsledek na webu

<a href="http://dx.doi.org/10.1111/j.1537-2995.2011.03536.x" target="_blank" >http://dx.doi.org/10.1111/j.1537-2995.2011.03536.x</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/j.1537-2995.2011.03536.x" target="_blank" >10.1111/j.1537-2995.2011.03536.x</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section

Popis výsledku v původním jazyce

When performing D alloimmunization prophylaxis in D- women after delivery of an D+ child, RhIG is often administered in a standard dose that is much higher than truly necessary. To precisely determine the dose of immunoglobulin (Ig) G anti-D needed to prevent D alloimmunization, it is necessary to determine the volume of incompatible fetal red blood cells (RBCs) that have entered the maternal circulation. If the volume of fetomaternal hemorrhage (FMH) is not assessed, usually an IgG anti-D dose of 100 to 300 mg is administered intramuscularly. The effectiveness of administering a standard dose of more than 100 mg to all women has not been demonstrated.1-10 The goal of further studies should be establishing optimal doses of IgG anti-D. The effectivenessof immediate administration of lower doses of IgG anti-D in combination with screening of the volume of FMH and subsequent supplementation of IgG anti-D in case of necessity should be compared with the effectiveness of administering a si

Název v anglickém jazyce

Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section

Popis výsledku anglicky

When performing D alloimmunization prophylaxis in D- women after delivery of an D+ child, RhIG is often administered in a standard dose that is much higher than truly necessary. To precisely determine the dose of immunoglobulin (Ig) G anti-D needed to prevent D alloimmunization, it is necessary to determine the volume of incompatible fetal red blood cells (RBCs) that have entered the maternal circulation. If the volume of fetomaternal hemorrhage (FMH) is not assessed, usually an IgG anti-D dose of 100 to 300 mg is administered intramuscularly. The effectiveness of administering a standard dose of more than 100 mg to all women has not been demonstrated.1-10 The goal of further studies should be establishing optimal doses of IgG anti-D. The effectivenessof immediate administration of lower doses of IgG anti-D in combination with screening of the volume of FMH and subsequent supplementation of IgG anti-D in case of necessity should be compared with the effectiveness of administering a si

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FK - Gynekologie a porodnictví

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Transfusion

ISSN

0041-1132

e-ISSN

—

Svazek periodika

52

Číslo periodika v rámci svazku

9

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

6

Strana od-do

1977-1982

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—